Calcipotriene/betamethasone dipropionate aerosol foam regulatory update

FDA approved Enstilar calcipotriene/betamethasone to treat plaque psoriasis in patients ages >=18 years. Leo plans to launch the aerosol foam formulation of a fixed-dose combination of 0.005% calcipot...